Labiotech 27 may 2026 The future of organ transplants: Xenotransplantation, 3D bioprinting and stem cells
Labiotech 25 may 2026 Blockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?
Labiotech 22 may 2026 The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Labiotech 19 may 2026 Reducing cell culture contamination: Why sterilisation validation matters in CO₂ shaking workflows